Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
Thrombosis Research|November 22, 2021
Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRYSandra Marten, Christiane Naue, Luise Tittl, et al.
International Journal of Cardiology|February 20, 2019
Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney diseaseFlorian Posch, Cihan Ay, Herbert Stöger, et al.
Journal of Gastroenterology|May 12, 2017
Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registryVera Heublein, Sven Pannach, Katharina Daschkow, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|February 7, 2013
Predictors of deep venous thrombosis in patients admitted to rehabilitation clinics after major orthopaedic surgeryJan Beyer-Westendorf, Vitalie Bogorad, Ingeborg Tautenhahn, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 17, 2025
Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRYLuise Tittl, Christina Köhler, Sandra Marten, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney diseaseFlorian Posch, Cihan Ay, Herbert Stöger, et al.
MMW Fortschritte Der Medizin|April 27, 2021
[Persistent dyspnea after COVID-19: Suggestions for follow-up care]Martin Kolditz, Jan Beyer-Westendorf, Simone von Bonin, et al.
Hamostaseologie|November 22, 2023
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k GuidelineHanno Riess, Jan Beyer-Westendorf, Uwe Pelzer, et al.
Thrombosis and Haemostasis|September 15, 2016
Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practiceJan Beyer-Westendorf, A John Camm, Craig I Coleman, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of AnticoagulationNakisa Khorsand, Jan Beyer-Westendorf, Ravi Sarode, et al.
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
Thrombosis Research|November 22, 2021
Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRYSandra Marten, Christiane Naue, Luise Tittl, et al.
International Journal of Cardiology|February 20, 2019
Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney diseaseFlorian Posch, Cihan Ay, Herbert Stöger, et al.
Journal of Gastroenterology|May 12, 2017
Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registryVera Heublein, Sven Pannach, Katharina Daschkow, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|February 7, 2013
Predictors of deep venous thrombosis in patients admitted to rehabilitation clinics after major orthopaedic surgeryJan Beyer-Westendorf, Vitalie Bogorad, Ingeborg Tautenhahn, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 17, 2025
Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRYLuise Tittl, Christina Köhler, Sandra Marten, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney diseaseFlorian Posch, Cihan Ay, Herbert Stöger, et al.
MMW Fortschritte Der Medizin|April 27, 2021
[Persistent dyspnea after COVID-19: Suggestions for follow-up care]Martin Kolditz, Jan Beyer-Westendorf, Simone von Bonin, et al.
Hamostaseologie|November 22, 2023
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k GuidelineHanno Riess, Jan Beyer-Westendorf, Uwe Pelzer, et al.
Thrombosis and Haemostasis|September 15, 2016
Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practiceJan Beyer-Westendorf, A John Camm, Craig I Coleman, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of AnticoagulationNakisa Khorsand, Jan Beyer-Westendorf, Ravi Sarode, et al.
Pageof 23